Thomson Erin Ator 4

4 · Shattuck Labs, Inc. · Filed Jan 12, 2022

Form 4

Period: 2022-01-10

General Counsel

Transactions

Award
Stock Option (Right to Buy)
2022-01-10+45,650→ 45,650 total
Exercise: $7.43Exp: 2032-01-10→ Common Stock (45,650 underlying)
Award
Common Stock
2022-01-10+22,825→ 69,084 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-01-12−10,000→ 53,705 total
Exercise: $2.95Exp: 2028-09-18→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2022-01-12$2.95/sh+10,000$29,500→ 79,084 total

Footnotes (3)

[F1]Consists of 22,825 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2023, subject to the Reporting Person's continued service to the Issuer.
[F2]This option represented a right to purchase a total of 45,650 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2023, with the remaining three quarters vesting in equal monthly installments through January 10, 2026, subject to the Reporting Person's continued service to the Issuer.
[F3]This option represents the right to purchase a total of 63,705 shares of the Issuer's common stock, 15,925 of which vested on May 15, 2019, with the remaining shares vesting in equal monthly installments through May 15, 2022.

Documents

1 file